null
100% Quality Guarantee
PhD-Level Technical Support
Key Features

GenieFluor Red 780 Anti-Human CD62L Antibody [DREG56] (AGEL2961)

SKU AGEL2961
Product Type Antibody
Antibody Type Monoclonal Antibody
Applications FCM
Reactivity Human
Host Species Mouse
Isotype Mouse IgG1, κ
Clone DREG56
Conjugation AFRed 780
€65 - €250
Global Shipping: 80+ Countries
White Glove Service: Available upon request
Batch Consistency: Contact Sales
Distributors: 60+ Countries

Description

system_update_altDatasheetsystem_update_altMSDS

GenieFluor Red 780 Anti-Human CD62L Antibody [DREG56]

The GenieFluor Red 780 Anti-Human CD62L Antibody (DREG56) offered by AssayGenie is a cutting-edge tool for researchers delving into the cellular dynamics of immune responses. This antibody, specifically targeting CD62L, a key adhesion molecule involved in lymphocyte trafficking and activation, is meticulously designed to provide high specificity and sensitivity in detecting human CD62L in various experimental setups.Through a rigorous development process, the GenieFluor Red 780 Anti-Human CD62L Antibody (DREG56) has been engineered to excel in applications such as flow cytometry, immunofluorescence, and immunohistochemistry. Its superior performance in recognizing CD62L enables precise identification and analysis of lymphocyte subsets expressing this crucial marker, facilitating in-depth investigations into immune cell behavior and function.

With its validated reactivity with human samples, the GenieFluor Red 780 Anti-Human CD62L Antibody (DREG56) ensures reliable and reproducible results, making it a valuable asset for studies encompassing immunology, inflammation, and related fields. By unlocking the intricacies of CD62L-mediated processes, researchers can broaden their understanding of immune cell interactions and potentially uncover new therapeutic targets for diseases involving immune dysregulation.In conclusion, the GenieFluor Red 780 Anti-Human CD62L Antibody (DREG56) stands at the forefront of innovative research tools, empowering scientists to delve deeper into the complexities of immune responses and pave the way for advancements in immunotherapy, autoimmune disease treatment, and beyond.

0 Reviews

0
Based on 0 reviews

No reviews yet. Be the first to share your experience!

View AllClose